These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 24933294)
21. A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis. Stitelman OM; De Gruttola V; van der Laan MJ Int J Biostat; 2012 Sep; 8(1):. PubMed ID: 22992289 [TBL] [Abstract][Full Text] [Related]
22. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias. Cai B; Small DS; Have TR Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062 [TBL] [Abstract][Full Text] [Related]
23. Severity of bias of a simple estimator of the causal odds ratio in Mendelian randomization studies. Harbord RM; Didelez V; Palmer TM; Meng S; Sterne JA; Sheehan NA Stat Med; 2013 Mar; 32(7):1246-58. PubMed ID: 23080538 [TBL] [Abstract][Full Text] [Related]
25. Many replications do not causal inferences make: the need for critical replications to test competing explanations of nonrandomized studies. Larzelere RE; Cox RB; Swindle TM Perspect Psychol Sci; 2015 May; 10(3):380-9. PubMed ID: 25987516 [TBL] [Abstract][Full Text] [Related]
26. The use of multilevel analysis for integrating single-case experimental design results within a study and across studies. Baek EK; Moeyaert M; Petit-Bois M; Beretvas SN; Van den Noortgate W; Ferron JM Neuropsychol Rehabil; 2014; 24(3-4):590-606. PubMed ID: 24047454 [TBL] [Abstract][Full Text] [Related]
27. Blinded and unblinded internal pilot study designs for clinical trials with count data. Schneider S; Schmidli H; Friede T Biom J; 2013 Jul; 55(4):617-33. PubMed ID: 23703749 [TBL] [Abstract][Full Text] [Related]
28. Estimating treatment effect via simple cross design synthesis. Kaizar EE Stat Med; 2011 Nov; 30(25):2986-3009. PubMed ID: 21898521 [TBL] [Abstract][Full Text] [Related]
30. Adjustment for baseline measurement error in randomized controlled trials induces bias. Chan SF; Macaskill P; Irwig L; Walter SD Control Clin Trials; 2004 Aug; 25(4):408-16. PubMed ID: 15296815 [TBL] [Abstract][Full Text] [Related]
31. A definition of causal effect for epidemiological research. HernĂ¡n MA J Epidemiol Community Health; 2004 Apr; 58(4):265-71. PubMed ID: 15026432 [TBL] [Abstract][Full Text] [Related]
32. Transportability of Trial Results Using Inverse Odds of Sampling Weights. Westreich D; Edwards JK; Lesko CR; Stuart E; Cole SR Am J Epidemiol; 2017 Oct; 186(8):1010-1014. PubMed ID: 28535275 [TBL] [Abstract][Full Text] [Related]
33. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation. Waernbaum I Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267 [TBL] [Abstract][Full Text] [Related]
34. Beyond intention to treat: what is the right question? Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636 [TBL] [Abstract][Full Text] [Related]
35. Re: The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Shrier I Stat Med; 2008 Jun; 27(14):2740-1; author reply 2741-2. PubMed ID: 18069729 [No Abstract] [Full Text] [Related]
36. [Propensity score methods for creating covariate balance in observational studies]. Pattanayak CW; Rubin DB; Zell ER Rev Esp Cardiol; 2011 Oct; 64(10):897-903. PubMed ID: 21872981 [TBL] [Abstract][Full Text] [Related]
37. Statistical analysis and design for estimating accuracy in clinical-center classification of cause-specific clinical events in clinical trials. Yan G; Greene T Clin Trials; 2011 Oct; 8(5):571-80. PubMed ID: 22013170 [TBL] [Abstract][Full Text] [Related]
38. Using the instrumental variables estimator to analyze noninferiority trials with noncompliance. Kim MY J Biopharm Stat; 2010 Jul; 20(4):745-58. PubMed ID: 20496203 [TBL] [Abstract][Full Text] [Related]
39. Pure and hybrid causal effects on variables associated with an incident event. Jiang Q; Snapinn S J Biopharm Stat; 2013; 23(4):719-29. PubMed ID: 23786519 [TBL] [Abstract][Full Text] [Related]
40. Evaluating dynamic treatment strategies: does it have to be more costly? Buyze J; Goetghebeur E Pharm Stat; 2013; 12(1):35-42. PubMed ID: 23208788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]